These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36072876)
61. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK; Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621 [TBL] [Abstract][Full Text] [Related]
62. Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome. Dharma S Int J Angiol; 2020 Jun; 29(2):81-87. PubMed ID: 32476809 [TBL] [Abstract][Full Text] [Related]
63. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Vranckx P; Goette A; Gibson CM; Alexander JH JAMA Cardiol; 2020 May; 5(5):582-589. PubMed ID: 32101251 [TBL] [Abstract][Full Text] [Related]
64. Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis. Zhu Y; Meng S; Chen M; Jia R; Nan J; Li H; Zhu H; Li L; Jin Z Cardiovasc Drugs Ther; 2021 Oct; 35(5):995-1002. PubMed ID: 33030686 [TBL] [Abstract][Full Text] [Related]
65. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort. Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049 [TBL] [Abstract][Full Text] [Related]
66. Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. Park J; Choi EK; Han KD; Choi YJ; Lee E; Choe W; Lee SR; Cha MJ; Lim WH; Kang J; Park KW; Oh S; Lip GYH PLoS One; 2019; 14(1):e0209593. PubMed ID: 30645601 [TBL] [Abstract][Full Text] [Related]
67. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry. Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592 [TBL] [Abstract][Full Text] [Related]
68. Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories. Ishii M; Kaikita K; Yasuda S; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H; Tsujita K; JACC Asia; 2022 Dec; 2(7):882-893. PubMed ID: 36713761 [TBL] [Abstract][Full Text] [Related]
69. Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents. Seivani Y; Abdel-Wahab M; Geist V; Richardt G; Sulimov DS; El-Mawardy M; Toelg R; Akin I Clin Res Cardiol; 2013 Nov; 102(11):799-806. PubMed ID: 23771774 [TBL] [Abstract][Full Text] [Related]
70. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Kopin D; Jones WS; Sherwood MW; Wojdyla DM; Wallentin L; Lewis BS; Verheugt FWA; Vinereanu D; Bahit MC; Halvorsen S; Huber K; Parkhomenko A; Granger CB; Lopes RD; Alexander JH Am Heart J; 2018 Mar; 197():133-141. PubMed ID: 29447773 [TBL] [Abstract][Full Text] [Related]
71. Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial. Cho MS; Kang DY; Oh YS; Lee CH; Choi EK; Lee JH; Kwon CH; Park GM; Park HW; Park KH; Park KM; Hwang J; Yoo KD; Cho YR; Kim YR; Hwang KW; Jin ES; Kim PJ; Kim KH; Park DW; Nam GB Am Heart J; 2022 May; 247():123-131. PubMed ID: 35149036 [TBL] [Abstract][Full Text] [Related]
72. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry. Sherwood MW; Piccini JP; Holmes DN; Pieper KS; Steinberg BA; Fonarow GC; Allen LA; Naccarelli GV; Kowey PR; Gersh BJ; Mahaffey KW; Singer DE; Ansell JE; Freeman JV; Chan PS; Reiffel JA; Blanco R; Peterson ED; Rao SV Circ Cardiovasc Interv; 2020 May; 13(5):e008274. PubMed ID: 32408815 [TBL] [Abstract][Full Text] [Related]
73. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry. Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443 [TBL] [Abstract][Full Text] [Related]
74. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis. Chen CF; Chen B; Zhu J; Xu YZ Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462 [TBL] [Abstract][Full Text] [Related]
75. Dual-Antithrombotic Therapy With DOACs After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials. Shurrab M; Danon A; Alnasser S; Glover B; Kaoutskaia A; Henderson M; Newman D; Crystal E; Ko D Can J Cardiol; 2020 Jan; 36(1):135-142. PubMed ID: 31874747 [TBL] [Abstract][Full Text] [Related]
76. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Goto K; Nakai K; Shizuta S; Morimoto T; Shiomi H; Natsuaki M; Yahata M; Ota C; Ono K; Makiyama T; Nakagawa Y; Furukawa Y; Kadota K; Takatsu Y; Tamura T; Takizawa A; Inada T; Doi O; Nohara R; Matsuda M; Takeda T; Kato M; Shirotani M; Eizawa H; Ishii K; Lee JD; Takahashi M; Horie M; Takahashi M; Miki S; Aoyama T; Suwa S; Hamasaki S; Ogawa H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T; Am J Cardiol; 2014 Jul; 114(1):70-8. PubMed ID: 24925801 [TBL] [Abstract][Full Text] [Related]
77. Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry). Rubboli A; Magnavacchi P; Guastaroba P; Saia F; Vignali L; Giacometti P; Franco N; Benassi A; Varani E; Campo G; Manari A; De Palma R; Marzocchi A Am J Cardiol; 2012 May; 109(10):1411-7. PubMed ID: 22342850 [TBL] [Abstract][Full Text] [Related]
78. Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention. Boivin-Proulx LA; Potter BJ; Dorais M; Perreault S CJC Open; 2023 Jan; 5(1):15-23. PubMed ID: 36700177 [TBL] [Abstract][Full Text] [Related]
79. [Antithrombotic treatment in acute coronary syndrome and atrial fibrillation]. Darius H; Görge G; Spiecker M; Schinzel H Herz; 2019 Feb; 44(1):29-34. PubMed ID: 30689009 [TBL] [Abstract][Full Text] [Related]
80. [Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Darius H Dtsch Med Wochenschr; 2020 Jul; 145(14):978-986. PubMed ID: 32668469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]